These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18559771)

  • 1. Clinical research in cutaneous T-cell lymphoma moving forward.
    Sterry W; Heinzerling L
    Arch Dermatol; 2008 Jun; 144(6):786-7. PubMed ID: 18559771
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of single-agent chemotherapy with pegylated liposomal doxorubicin or gemcitabine in a diverse cohort of patients with recalcitrant cutaneous T-cell lymphoma.
    Weiner D; Ly A; Talluru S; Munjal A; Pierog O; Ambinder R; Rozati S
    Br J Dermatol; 2024 Feb; 190(3):436-438. PubMed ID: 37655919
    [No Abstract]   [Full Text] [Related]  

  • 3. Pegylated doxorubicin for primary cutaneous T cell lymphoma: a report on ten patients with follow-up.
    Wollina U; Graefe T; Kaatz M
    Ann N Y Acad Sci; 2001 Sep; 941():214-6. PubMed ID: 11594577
    [No Abstract]   [Full Text] [Related]  

  • 4. Retrospective study of spectrum of cutaneous lymphoma presenting to dermatology.
    Doshi BR; Khopkar US
    Indian J Dermatol Venereol Leprol; 2011; 77(4):512-5. PubMed ID: 21727703
    [No Abstract]   [Full Text] [Related]  

  • 5. Classification of cutaneous T-cell lymphoma: from Alibert to WHO-EORTC.
    Willemze R; Meijer CJ
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():18-26. PubMed ID: 16412209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sudden onset of an aggressive cutaneous lymphoma in a young patient with psoriasis: role of immunosuppressants.
    Quéreux G; Renaut JJ; Peuvrel L; Knol AC; Brocard A; Dréno B
    Acta Derm Venereol; 2010 Nov; 90(6):616-20. PubMed ID: 21057746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cutaneous lymphoma].
    Beyeler M; Burg G; Dummer R
    Hautarzt; 2004 Oct; 55(10):1005-16; quiz 1017. PubMed ID: 15349694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pegylated liposomal doxorubicin in the treatment of mycosis fungoides.
    Lybaek D; Iversen L
    Acta Derm Venereol; 2006; 86(6):545-7. PubMed ID: 17106606
    [No Abstract]   [Full Text] [Related]  

  • 9. Immediate hypersensitivity reaction to pegylated liposomal doxorubicin: management and outcome in four patients.
    Ingen-Housz-Oro S; Pham-Ledard A; Brice P; Lebrun-Vignes B; Zehou O; Reitter D; Ram-Wolff C; Dupin N; Bagot M; Chosidow O; Beylot-Barry M
    Eur J Dermatol; 2017 Jun; 27(3):271-274. PubMed ID: 28524061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential for Teledermatology in Managing and Diagnosing Patients With Cutaneous Lymphomas.
    Beer J; Hadeler E; Nouri K
    J Drugs Dermatol; 2020 Nov; 19(11):1125. PubMed ID: 33196742
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies.
    Pulini S; Rupoli S; Goteri G; Pimpinelli N; Alterini R; Bettacchi A; Mulattieri S; Picardi P; Tassetti A; Scortechini AR; Fioritoni G; Leoni P
    Eur J Haematol; 2009 Mar; 82(3):184-93. PubMed ID: 19215609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of advanced cutaneous T-cell lymphoma: role of the dermatologist in the multidisciplinary team.
    Poligone B; Querfeld C
    Br J Dermatol; 2015 Oct; 173(4):1081-3. PubMed ID: 25894580
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with advanced or refractory mycosis fungoides or Sézary syndrome.
    Quereux G; Marques S; Nguyen JM; Bedane C; D'incan M; Dereure O; Puzenat E; Claudy A; Martin L; Joly P; Delaunay M; Beylot-Barry M; Vabres P; Celerier P; Sasolas B; Grange F; Khammari A; Dreno B
    Arch Dermatol; 2008 Jun; 144(6):727-33. PubMed ID: 18559761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Sézary syndrome a true primary cutaneous lymphoma?
    Alaibac M; Pigozzi B; Bordignon M
    Int J Dermatol; 2008 Nov; 47(11):1195-6. PubMed ID: 18986460
    [No Abstract]   [Full Text] [Related]  

  • 15. Classification of cutaneous lymphomas.
    Slater D
    Arch Dermatol; 1996 Aug; 132(8):972-4. PubMed ID: 8712854
    [No Abstract]   [Full Text] [Related]  

  • 16. [Definition, classification, clinical and histological diagnosis of cutaneous T-cell lymphomas].
    Beylot-Barry M
    Ann Dermatol Venereol; 2005 Sep; 132 Spec No 2():5S5-10. PubMed ID: 16385891
    [No Abstract]   [Full Text] [Related]  

  • 17. Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas.
    Fabbri A; Cencini E; Alterini R; Rubegni P; Rigacci L; Delfino C; Puccini B; Fimiani M; Bosi A; Bocchia M; Pimpinelli N;
    Eur J Haematol; 2014 Aug; 93(2):129-36. PubMed ID: 24635751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of primary cutaneous T-cell lymphomas.
    Slater DN
    Histopathology; 1995 Jan; 26(1):99-101. PubMed ID: 7713490
    [No Abstract]   [Full Text] [Related]  

  • 19. Distinct subtypes of subcutaneous T-cell lymphoma.
    Burg G; Dummer R; Nestle F
    Arch Dermatol; 1994 Aug; 130(8):1073. PubMed ID: 8053710
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary cutaneous follicular helper T-cell lymphoma: diagnostic pitfalls of this new lymphoma subtype.
    Buder K; Poppe LM; Bröcker EB; Goebeler M; Rosenwald A; Geissinger E; Kerstan A
    J Cutan Pathol; 2013 Oct; 40(10):903-8. PubMed ID: 23941646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.